Actively Recruiting
Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
Led by Charite University, Berlin, Germany · Updated on 2023-07-03
2000
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.
CONDITIONS
Official Title
Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of advanced cancer
- Ability to provide written informed consent
- Performance status that allows starting a potential targeted treatment after molecular analysis
- Molecular analysis has been completed or is planned
You will not qualify if you...
- Unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Charité Comprehensive Cancer Center
Berlin, Germany, 10117
Actively Recruiting
Research Team
D
Damian T Rieke, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here